R. R. Holman

1.6k total citations
20 papers, 1.2k citations indexed

About

R. R. Holman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, R. R. Holman has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 4 papers in Physiology. Recurrent topics in R. R. Holman's work include Diabetes Treatment and Management (6 papers), Diabetes and associated disorders (4 papers) and Pancreatic function and diabetes (4 papers). R. R. Holman is often cited by papers focused on Diabetes Treatment and Management (6 papers), Diabetes and associated disorders (4 papers) and Pancreatic function and diabetes (4 papers). R. R. Holman collaborates with scholars based in United Kingdom, United States and Australia. R. R. Holman's co-authors include Anne Clark, R. C. Turner, David R. Matthews, J.K. Cruickshank, Garth J. S. Cooper, I Buley, Christopher A. Wells, R I Vanhegan, Irene Stratton and Alastair Gray and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetologia and Psychoneuroendocrinology.

In The Last Decade

R. R. Holman

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. R. Holman United Kingdom 12 510 509 317 235 219 20 1.2k
Roger L. Lerner United States 14 910 1.8× 610 1.2× 273 0.9× 438 1.9× 180 0.8× 18 1.4k
Yuji Tajiri Japan 17 414 0.8× 296 0.6× 120 0.4× 325 1.4× 233 1.1× 73 1.1k
Marco Campioni Italy 12 853 1.7× 472 0.9× 264 0.8× 340 1.4× 158 0.7× 16 1.3k
Olga T. Hardy United States 12 448 0.9× 325 0.6× 159 0.5× 352 1.5× 298 1.4× 19 1.2k
Annette M. Chang United States 16 811 1.6× 460 0.9× 211 0.7× 300 1.3× 184 0.8× 30 1.4k
Mark Stolar United States 16 1.1k 2.1× 196 0.4× 238 0.8× 181 0.8× 107 0.5× 23 1.4k
J Insel United States 7 594 1.2× 335 0.7× 129 0.4× 594 2.5× 160 0.7× 8 1.3k
Wataru Kameda Japan 19 292 0.6× 177 0.3× 140 0.4× 309 1.3× 400 1.8× 49 1.2k
Angelo Di Vincenzo Italy 16 1.2k 2.4× 708 1.4× 458 1.4× 207 0.9× 281 1.3× 54 1.8k
Henna Cederberg Finland 21 536 1.1× 360 0.7× 140 0.4× 451 1.9× 317 1.4× 37 1.5k

Countries citing papers authored by R. R. Holman

Since Specialization
Citations

This map shows the geographic impact of R. R. Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. R. Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. R. Holman more than expected).

Fields of papers citing papers by R. R. Holman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. R. Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. R. Holman. The network helps show where R. R. Holman may publish in the future.

Co-authorship network of co-authors of R. R. Holman

This figure shows the co-authorship network connecting the top 25 collaborators of R. R. Holman. A scholar is included among the top collaborators of R. R. Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. R. Holman. R. R. Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yates, Thomas, Melanie J. Davies, Steven M. Haffner, et al.. (2015). Physical activity as a determinant of fasting and 2‐h post‐challenge glucose: a prospective cohort analysis of the NAVIGATOR trial. Diabetic Medicine. 32(8). 1090–1096. 11 indexed citations
2.
Alva, María, Alastair Gray, Borislava Mihaylova, José Leal, & R. R. Holman. (2014). The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84). Diabetic Medicine. 32(4). 459–466. 162 indexed citations
3.
Holman, R. R., Sanjoy K. Paul, & Angelyn Bethel. (2009). Ten-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. Journal of Vascular Surgery. 49(1). 272–272. 16 indexed citations
4.
Cull, C A, H. A. W. Neil, & R. R. Holman. (2004). Changing aspirin use in patients with Type 2 diabetes in the UKPDS. Diabetic Medicine. 21(12). 1368–1371. 34 indexed citations
5.
Viberti, Gian Carlo, et al.. (2003). Prevalence of microalbuminuria in recently diagnosed Type 2 diabetes mellitus and its relationship to non-traditional risk factors: observations from the ADOPT study. Diabetologia. 46. 1 indexed citations
6.
Clarke, Philip, Alastair Gray, Amanda Adler, et al.. (2001). Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51). Diabetologia. 44(3). 298–304. 74 indexed citations
7.
Hashim, Y, Dawn Shepherd, R. R. Holman, et al.. (2001). Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects. Diabetologia. 44(12). 2227–2230. 41 indexed citations
8.
Horton, V., Irene Stratton, G. F. Bottazzo, et al.. (1999). Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). Diabetologia. 42(5). 608–616. 88 indexed citations
9.
Stratton, Irene, et al.. (1997). Evaluating risk of progression to photocoagulation by retinal photography or direct ophthalmoscopy.. Diabetologia. 40. 60–60. 1 indexed citations
10.
Widjaja, A., Irene Stratton, Robert C. Horn, et al.. (1997). UKPDS 20: Plasma Leptin, Obesity, and Plasma Insulin in Type 2 Diabetic Subjects. The Journal of Clinical Endocrinology & Metabolism. 82(2). 654–657. 147 indexed citations
11.
Turner, Robert C. & R. R. Holman. (1996). The UK Prospective Diabetes Study. Annals of Medicine. 28(5). 439–444. 28 indexed citations
12.
Holman, R. R., J Steemson, & R. C. Turner. (1991). Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia.. PubMed. 18(4). 149–53. 9 indexed citations
13.
Holman, R. R.. (1990). UK prospective diabetes study. Oxford University Research Archive (ORA) (University of Oxford). 154–158. 1 indexed citations
14.
Clark, Anne, Christopher A. Wells, I Buley, et al.. (1988). Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.. PubMed. 9(4). 151–9. 432 indexed citations
15.
Howard-Williams, J., et al.. (1986). Quantifying early diabetic retinopathy. Diabetologia. 29(11). 761–766. 3 indexed citations
16.
Clark, Anne, R. R. Holman, David R. Matthews, T. D. R. Hockaday, & R. C. Turner. (1984). Non-uniform distribution of islet amyloid in the pancreas of ?maturity-onset? diabetic patients. Diabetologia. 27(5). 527–528. 21 indexed citations
17.
Francis, Paul C., et al.. (1984). The effect of testosterone on the release of endogenous catecholamines from the hypothalamus of the cockerel in vitro. Psychoneuroendocrinology. 9(1). 69–76. 10 indexed citations
18.
Shaw, D B, R. R. Holman, & J. I. Gowers. (1980). Survival in sinoatrial disorder (sick-sinus syndrome).. BMJ. 280(6208). 139–141. 123 indexed citations
19.
Phillips, Margaret A., R. W. Simpson, R. R. Holman, & R. C. Turner. (1979). A Simple and Rational Twice Daily Insulin Regime. QJM. 48(3). 493–506. 17 indexed citations
20.
Turner, R. C., R. R. Holman, & T. D. R. Hockaday. (1976). Beta Cell Deficiency in Maturity Onset Diabetes. Clinical Science. 51(3). 18P–18P. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026